Manufacturing
-
State-of-the-Art GMP Manufacturing RNA Cell Therapies With Cartesian's CEO
8/19/2021
Dr. Murat Kalayoglu, CEO at Cartesian Therapeutics, details the cell and gene therapy sector's advancements in RNA cell therapy and the why behind the company's decision to build its own wholly-owned GMP manufacturing facility.
-
The Future Of Cell And Organ Transplantation In Treating T1D With Dr. Camillo Ricordi
10/10/2023
Explore the biggest and most troubling challenges facing the treatment of Type 1 Diabetes (T1D) and the future of cell and organ transplantation in treating T1D as well as the latest innovations in biopreservation.